Back
HFA Premium Access

Elegibility for sacubitril/valsartan utilization in acute heart failure

Session: Poster Session 2 - Acute Heart Failure– Treatment
Topic: Treatment
Speaker: Associate Professor L. Passos (Salvador, BR)
Event: Heart Failure 2018

Congress Presentation

Add to my library

Like

About the speaker

Associate Professor Luiz Carlos Passos

Federal University of Bahia, Salvador (Brazil)
0 follower

11 more presentations in this session

Digoxin and Prognosis of Heart Failure in Older Patients with Preserved Ejection Fraction: Importance of Heart Rate

Speaker: Doctor P. Llacer (Madrid, ES)

Access
Abstract
Like
Thumbnail

Efficacy of Tolvaptan for the first hospitalized patients with acute decompensated heart failure

Speaker: Doctor Y. Suzuki (Nagakute-cho, JP)

Access
Abstract
Slides
Like
Thumbnail

Safety and efficacy of tolvaptan administration in patients hospitalised for acute decompensated heart failure due to moderate or severe aortic stenosis

Speaker: Doctor R. Hata (Kurashiki, JP)

Access
Abstract
Slides
Like
Thumbnail

Effects of low dose levosimendan on renal function in patients with advanced heart failure

Speaker: Doctor R. Dierckx (Aalst, BE)

Access
Abstract
Like
Thumbnail

Using Levosimanden in place for unresponsive acute decompensated heart failure to dobutamine

Speaker: Doctor M. Chou (Tainan, TW)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 2 - Acute Heart Failure– Treatment

Speakers: Associate Professor L. Passos, Doctor P. Llacer, Doctor Y. Suzuki, Doctor R. Hata, Doctor R. Dierckx...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources